2025 Efficacy and safety of CAR T-cell therapy in patients with primary or secondary CNS lymphoma: A study on behalf of the EBMT and the GoCART coalition Group Lymphoma Working Party (LWP) GoCART Coalition 1st listed author Anna Ossami Saidy Journal Hemasphere.
2025 Addition of mycophenolate mofetil to a calcineurin inhibitor and post-transplant cyclophosphamide results in lower incidence of extensive chronic graft-versus-host disease in HLA-matched allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia in complete remission: a matched-pair analysis on behalf of the Acute Leukemia Working Party of the EBMT Group Acute Leukemia Working Party (ALWP) 1st listed author Giorgia Battipaglia Journal Bone Marrow Transplant.
2025 CAR-T cell manufacturing failures and out-of-specification products in the real-world setting: A survey from the EBMT cellular therapy and immunobiology working party Group Cellular Therapy & Immunobiology Working Party (CTIWP) 1st listed author Nina Worel Journal Bone Marrow Transplant.
2025 International expert consensus statement on PICU admission and early critical care management for paediatric patients following haematopoietic cell transplant and immune effector cell therapy Group Paediatric Diseases Working Party (PDWP) WP/Committee not specified 1st listed author Matteo Di Nardo Journal Lancet Child Adolesc Health.
2025 "Learn and Know" in the era of gene addition/gene editing based approaches for sickle cell disease: The EHA-EBMT consensus paper Group Haemoglobinopathies Working Party (HWP) Other society 1st listed author Lucia De Franceschi Journal Bone Marrow Transplant.
2025 Urgent need: evidence-based use of donor lymphocyte infusions - Authors' reply Group Cellular Therapy & Immunobiology Working Party (CTIWP) 1st listed author Simona Pagliuca Journal Lancet Haematol.
2025 Autologous stem cell transplantation for adults with Philadelphia-negative acute lymphoblastic leukemia in first complete remission. A study by the Acute Leukemia Working Party of the EBMT Group Acute Leukemia Working Party (ALWP) 1st listed author Ryszard Swoboda Journal BMC Cancer.
2025 Allogeneic stem cell transplantation in de novo core-binding factor acute myeloid leukemia in active disease: a study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation Group Acute Leukemia Working Party (ALWP) 1st listed author Sara Tarantino Journal Bone Marrow Transplant.
2025 Growing adoption of pharmacologic maintenance therapy after allogeneic hematopoietic cell transplantation in acute myeloid leukemia: a survey on behalf of the EBMT acute leukemia working party Group Acute Leukemia Working Party (ALWP) 1st listed author Iman Abou Dalle Journal Bone Marrow Transplant.
2025 Improved post-transplant outcomes since 2000 for Ph-positive acute lymphoblastic leukemia in first remission: A study from the EBMT Acute Leukemia Working Party Group Acute Leukemia Working Party (ALWP) 1st listed author Ali Bazarbachi Journal Hemasphere.
2025 The impact of ABO compatibility on allogeneic hematopoietic cell transplantation outcomes: a contemporary and comprehensive study from the transplant complications working party of the EBMT Group Transplant Complications Working Party (TCWP) 1st listed author Mustafa Güven Journal Bone Marrow Transplant.
2025 Outcomes of patients with Hodgkin lymphoma receiving Brentuximab Vedotin (BV) as maintenance therapy after ASCT according to previous exposure to BV. A retrospective analysis of the EBMT Lymphoma Working Party in collaboration with GELTAMO, FIL, LYSA, and Turkish Lymphoma Group Group Lymphoma Working Party (LWP) Other society 1st listed author Carmen Martínez Journal Bone Marrow Transplant.